Summary:
- This article discusses a new gene therapy approach to treat a rare genetic disorder called Duchenne muscular dystrophy (DMD).
- DMD is a debilitating condition that causes progressive muscle weakness and is caused by mutations in the dystrophin gene.
- The gene therapy technique described in the article aims to deliver a functional version of the dystrophin gene to muscle cells, potentially restoring muscle function and slowing the progression of the disease.